Literature DB >> 26037048

The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.

Frank Cichocki1, Michael R Verneris2, Sarah Cooley1, Veronika Bachanova1, Claudio G Brunstein1, Bruce R Blazar2, John Wagner2, Heinrich Schlums3, Yenan T Bryceson3,4, Daniel J Weisdorf1, Jeffrey S Miller5,6.   

Abstract

Hematopoietic cell transplantation (HCT) has been used as a part of cancer therapy for over half a decade. Beyond the necessity for donor-derived cells to reconstitute hematopoiesis after radiation and chemotherapy, immunologic reconstitution from allogeneic cells is important for the elimination of residual tumor cells. Natural killer (NK) cells are first among lymphocytes to reconstitute post-transplant and protect against cancer relapse. In this review, we provide a historical perspective on the role of NK cells in cancer control in the transplant setting and focus on current research aimed at improving NK cell responses for therapeutic benefit.

Entities:  

Mesh：

Year:  2016        PMID： 26037048      PMCID： PMC5870762          DOI： 10.1007/82_2015_445

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


  118 in total

1.  Cytological identification of radiation-chimaeras.

Authors:  C E FORD; J L HAMERTON; D W BARNES; J F LOUTIT
Journal:  Nature       Date:  1956-03-10       Impact factor: 49.962

2.  CMV-specific cellular therapy for acute myeloid leukemia?

Authors:  Kirsty J Thomson; Stephen Mackinnon; Karl S Peggs
Journal:  Blood       Date:  2012-01-26       Impact factor: 22.113

3.  Treatment of cytomegalovirus pneumonitis after bone marrow transplantation with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine.

Authors:  P Selby; R L Powles; B Jameson; K Stolle; Y Tryhorn; H Stern
Journal:  Lancet       Date:  1986-06-14       Impact factor: 79.321

4.  Allogeneic natural killer cells for refractory lymphoma.

Authors:  Veronika Bachanova; Linda J Burns; David H McKenna; Julie Curtsinger; Angela Panoskaltsis-Mortari; Bruce R Lindgren; Sarah Cooley; Daniel Weisdorf; Jeffrey S Miller
Journal:  Cancer Immunol Immunother       Date:  2010-08-03       Impact factor: 6.968

5.  Depressed natural killer function in transplant recipients: an analysis.

Authors:  E Dupont; K Huygen; L Schandene; M Vandercruys; K Palfliet; J Wybran
Journal:  Transplant Proc       Date:  1984-12       Impact factor: 1.066

6.  Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.

Authors:  P L Weiden; N Flournoy; E D Thomas; R Prentice; A Fefer; C D Buckner; R Storb
Journal:  N Engl J Med       Date:  1979-05-10       Impact factor: 91.245

7.  Human diversity in killer cell inhibitory receptor genes.

Authors:  M Uhrberg; N M Valiante; B P Shum; H G Shilling; K Lienert-Weidenbach; B Corliss; D Tyan; L L Lanier; P Parham
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

8.  Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients.

Authors:  Ahmet H Elmaagacli; Nina K Steckel; Michael Koldehoff; Yael Hegerfeldt; Rudolf Trenschel; Markus Ditschkowski; Sandra Christoph; Tanja Gromke; Lambros Kordelas; Hellmut D Ottinger; Rudolf S Ross; Peter A Horn; Susanne Schnittger; Dietrich W Beelen
Journal:  Blood       Date:  2011-05-03       Impact factor: 22.113

9.  Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

Authors:  Mónica Gumá; Ana Angulo; Carlos Vilches; Natalia Gómez-Lozano; Núria Malats; Miguel López-Botet
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

10.  A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission.

Authors:  F L Johnson; E D Thomas; B S Clark; R L Chard; J R Hartmann; R Storb
Journal:  N Engl J Med       Date:  1981-10-08       Impact factor: 91.245
View more
  12 in total

Review 1.  Harnessing adaptive natural killer cells in cancer immunotherapy.

Authors:  Lisa L Liu; Aline Pfefferle; Vincent Oei Yi Sheng; Andreas T Björklund; Vivien Béziat; Jodie P Goodridge; Karl-Johan Malmberg
Journal:  Mol Oncol       Date:  2015-10-20       Impact factor: 6.603

2.  GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.

Authors:  Mark D Bunting; Antiopi Varelias; Fernando Souza-Fonseca-Guimaraes; Iona S Schuster; Katie E Lineburg; Rachel D Kuns; Peter Fleming; Kelly R Locke; Nicholas D Huntington; Bruce R Blazar; Steven W Lane; Siok-Keen Tey; Kelli P A MacDonald; Mark J Smyth; Mariapia A Degli-Esposti; Geoffrey R Hill
Journal:  Blood       Date:  2016-12-07       Impact factor: 22.113

Review 3.  Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy.

Authors:  Huang Zhu; Yi-Shin Lai; Ye Li; Robert H Blum; Dan S Kaufman
Journal:  Stem Cells       Date:  2018-01-03       Impact factor: 6.277

4.  Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells.

Authors:  Heinrich Schlums; Moonjung Jung; Hongya Han; Jakob Theorell; Venetia Bigley; Samuel C C Chiang; David S J Allan; Jan K Davidson-Moncada; Rachel E Dickinson; Tim D Holmes; Amy P Hsu; Danielle Townsley; Thomas Winkler; Weixin Wang; Pål Aukrust; Ingvild Nordøy; Katherine R Calvo; Steve M Holland; Matthew Collin; Cynthia E Dunbar; Yenan T Bryceson
Journal:  Blood       Date:  2017-02-16       Impact factor: 22.113

5.  PD-1 is expressed in cytotoxic granules of NK cells and rapidly mobilized to the cell membrane following recognition of tumor cells.

Authors:  Cecilia Pesini; Sandra Hidalgo; Maykel A Arias; Llipsy Santiago; Carlota Calvo; Maitane Ocariz-Díez; Dolores Isla; Pilar M Lanuza; M José Agustín; Eva M Galvez; Ariel Ramírez-Labrada; Julián Pardo
Journal:  Oncoimmunology       Date:  2022-07-06       Impact factor: 7.723

Review 6.  Planes, Trains, and Automobiles: Perspectives on CAR T Cells and Other Cellular Therapies for Hematologic Malignancies.

Authors:  Saar Gill
Journal:  Curr Hematol Malig Rep       Date:  2016-08       Impact factor: 3.952

7.  Canonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C.

Authors:  Malcolm J W Sim; Stacy A Malaker; Ayesha Khan; Janet M Stowell; Jeffrey Shabanowitz; Mary E Peterson; Sumati Rajagopalan; Donald F Hunt; Daniel M Altmann; Eric O Long; Rosemary J Boyton
Journal:  Front Immunol       Date:  2017-03-14       Impact factor: 7.561

8.  Clonal expansion and compartmentalized maintenance of rhesus macaque NK cell subsets.

Authors:  Chuanfeng Wu; Diego A Espinoza; Samson J Koelle; Di Yang; Lauren Truitt; Heinrich Schlums; Bernard A Lafont; Jan K Davidson-Moncada; Rong Lu; Amitinder Kaur; Quirin Hammer; Brian Li; Sandhya Panch; David A Allan; Robert E Donahue; Richard W Childs; Chiara Romagnani; Yenan T Bryceson; Cynthia E Dunbar
Journal:  Sci Immunol       Date:  2018-11-02

9.  OMIP-080: 29-Color flow cytometry panel for comprehensive evaluation of NK and T cells reconstitution after hematopoietic stem cells transplantation.

Authors:  Sarka Vanikova; Abhishek Koladiya; Jan Musil
Journal:  Cytometry A       Date:  2021-10-24       Impact factor: 4.714

Review 10.  Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Md Ashik Ullah; Geoffrey R Hill; Siok-Keen Tey
Journal:  Front Immunol       Date:  2016-04-15       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.